• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏再同步治疗后急性血流动力学反应的超声心动图测量可预测长期临床结局。

Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome.

作者信息

Tournoux Francois B, Alabiad Chrisfouad, Fan Dali, Chen Annabel A, Chaput Miguel, Heist Edwin Kevin, Mela Theofanie, Mansour Moussa, Reddy Vivek, Ruskin Jeremy N, Picard Michael H, Singh Jagmeet P

机构信息

Cardiac Arrhythmia Service and Cardiac Ultrasound Laboratory, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston, MA 02114, USA.

出版信息

Eur Heart J. 2007 May;28(9):1143-8. doi: 10.1093/eurheartj/ehm050. Epub 2007 Apr 21.

DOI:10.1093/eurheartj/ehm050
PMID:17449877
Abstract

AIMS

Although acute haemodynamic improvement in response to cardiac resynchronization therapy (CRT) is reflective of a favourable cardiac contractile response, there is limited information regarding not only its ability to predict long-term clinical outcome but also cardiac-substrate-specific differences in the prognostic value of this measure.

METHODS AND RESULTS

Fifty-three heart failure patients (69 +/- 11 years) with low left ventricle ejection fraction (LVEF) (22 +/- 6%), wide QRS (169 +/- 31 ms), and indications for CRT were included. There were no significant differences in age, New York Heart Association (NYHA) class, medications, QRS width, or LVEF between ischaemic (n = 37) and non-ischaemic (n = 16) groups. Echocardiograms were performed within 24 h of implantation with device OFF and ON. Acute haemodynamic response was measured as LV dP/dt derived from the CW Doppler of mitral regurgitation. Percentage change in dP/dt was used to classify patients: high- (HR: DeltadP/dt > 25%) or poor-responders (PR: DeltadP/dt <or= 25%). Clinical response to CRT was defined by a combined endpoint of hospitalizations and all-cause mortality at 12 months. HR group had a significantly better outcome compared to the PR group (P-value = 0.004) irrespective of the aetiology of the cardiomyopathy.

CONCLUSION

Echocardiographic assessment of the acute haemodynamic response to CRT predicts long-term clinical outcome in both ischaemic and non-ischaemic cardiomyopathy.

摘要

目的

尽管心脏再同步治疗(CRT)引起的急性血流动力学改善反映了良好的心脏收缩反应,但关于其预测长期临床结局的能力以及该指标在不同心脏底物中的预后价值差异的信息有限。

方法与结果

纳入53例左心室射血分数(LVEF)低(22±6%)、QRS波增宽(169±31毫秒)且有CRT指征的心力衰竭患者(69±11岁)。缺血性心肌病组(n = 37)和非缺血性心肌病组(n = 16)在年龄、纽约心脏协会(NYHA)心功能分级、用药情况、QRS波宽度或LVEF方面无显著差异。在植入装置开启和关闭状态下,于植入后24小时内进行超声心动图检查。急性血流动力学反应通过二尖瓣反流的连续波多普勒测得的左心室dp/dt来衡量。dp/dt的变化百分比用于对患者进行分类:高反应者(HR:Δdp/dt>25%)或低反应者(PR:Δdp/dt≤25%)。CRT的临床反应通过12个月时的住院和全因死亡率综合终点来定义。无论心肌病的病因如何,HR组的结局均显著优于PR组(P值 = 0.004)。

结论

超声心动图评估CRT的急性血流动力学反应可预测缺血性和非缺血性心肌病的长期临床结局。

相似文献

1
Echocardiographic measures of acute haemodynamic response after cardiac resynchronization therapy predict long-term clinical outcome.心脏再同步治疗后急性血流动力学反应的超声心动图测量可预测长期临床结局。
Eur Heart J. 2007 May;28(9):1143-8. doi: 10.1093/eurheartj/ehm050. Epub 2007 Apr 21.
2
Left ventricular lead electrical delay predicts response to cardiac resynchronization therapy.左心室导联电延迟可预测心脏再同步治疗的反应。
Heart Rhythm. 2006 Nov;3(11):1285-92. doi: 10.1016/j.hrthm.2006.07.034. Epub 2006 Aug 10.
3
Left ventricular lead proximity to an akinetic segment and impact on outcome of cardiac resynchronization therapy.左心室电极靠近运动不能节段及其对心脏再同步治疗结果的影响。
J Cardiovasc Electrophysiol. 2006 Jun;17(6):623-7. doi: 10.1111/j.1540-8167.2006.00480.x.
4
Usefulness of a novel "response score" to predict hemodynamic and clinical outcome from cardiac resynchronization therapy.一种新型“反应评分”预测心脏再同步治疗血流动力学和临床结局的效用
Am J Cardiol. 2006 Jun 15;97(12):1732-6. doi: 10.1016/j.amjcard.2006.01.035. Epub 2006 Apr 21.
5
Spectral pulsed-wave tissue Doppler imaging lateral-to-septal delay fails to predict clinical or echocardiographic outcome after cardiac resynchronization therapy.频谱脉冲波组织多普勒成像测定的室间隔与侧壁延迟无法预测心脏再同步治疗后的临床或超声心动图结局。
Europace. 2007 Feb;9(2):113-8. doi: 10.1093/europace/eul149. Epub 2007 Jan 11.
6
Baseline left ventricular dP/dtmax rather than the acute improvement in dP/dtmax predicts clinical outcome in patients with cardiac resynchronization therapy.左心室 dp/dtmax 的基线值而非 dp/dtmax 的急性改善可预测心脏再同步治疗患者的临床转归。
Eur J Heart Fail. 2011 Oct;13(10):1126-32. doi: 10.1093/eurjhf/hfr094. Epub 2011 Jul 26.
7
Mechanical dyssynchrony by 3D echo correlates with acute haemodynamic response to biventricular pacing in heart failure patients.三维超声心动图检测的机械性不同步与心力衰竭患者双心室起搏的急性血流动力学反应相关。
Europace. 2008 Jan;10(1):63-8. doi: 10.1093/europace/eum262. Epub 2007 Dec 7.
8
Prediction of long-term outcome of cardiac resynchronization therapy by acute pressure-volume loop measurements.通过急性压力-容积环测量预测心脏再同步治疗的长期预后。
Eur J Heart Fail. 2013 Mar;15(3):299-307. doi: 10.1093/eurjhf/hfs190. Epub 2012 Nov 25.
9
Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial.心脏再同步化治疗改善左心室不同步与收缩功能的关系及其临床转归:MADIT-CRT 试验。
Eur Heart J. 2011 Jul;32(14):1720-9. doi: 10.1093/eurheartj/ehr185. Epub 2011 May 24.
10
Contractile response and mitral regurgitation after temporary interruption of long-term cardiac resynchronization therapy.长期心脏再同步治疗暂时中断后的收缩反应和二尖瓣反流
Eur Heart J. 2006 Jan;27(2):187-92. doi: 10.1093/eurheartj/ehi558. Epub 2005 Oct 13.

引用本文的文献

1
Assessment of the correlation between Doppler derived dP/dt and aortic velocity-time integral during cardiac resynchronization therapy optimization.心脏再同步治疗优化过程中多普勒衍生的dP/dt与主动脉速度-时间积分之间相关性的评估。
Int J Cardiovasc Imaging. 2024 Oct;40(10):2125-2132. doi: 10.1007/s10554-024-03204-w. Epub 2024 Aug 13.
2
Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis.心脏植入式电子设备后三尖瓣和二尖瓣反流的演变和预后:系统评价和荟萃分析。
Europace. 2024 Jul 2;26(7). doi: 10.1093/europace/euae143.
3
A multicenter prospective randomized controlled trial of cardiac resynchronization therapy guided by invasive dP/dt.
一项由有创dP/dt指导的心脏再同步治疗的多中心前瞻性随机对照试验。
Heart Rhythm O2. 2021 Jan 22;2(1):19-27. doi: 10.1016/j.hroo.2021.01.005. eCollection 2021 Feb.
4
Outflow Cannula Systolic Slope in Patients With Left Ventricular Assist Devices: A Novel Marker of Myocardial Contractility.左心室辅助装置患者的流出管收缩斜率:一种心肌收缩力的新标志物。
ASAIO J. 2019 Feb;65(2):160-166. doi: 10.1097/MAT.0000000000000799.
5
Rationale and design of a randomized trial to assess the safety and efficacy of MultiPoint Pacing (MPP) in cardiac resynchronization therapy: The MPP Trial.评估多点起搏(MPP)在心脏再同步治疗中的安全性和有效性的随机试验的原理与设计:MPP试验
Ann Noninvasive Electrocardiol. 2017 Nov;22(6). doi: 10.1111/anec.12448. Epub 2017 May 18.
6
Right ventricular lead adjustment in cardiac resynchronization therapy and acute hemodynamic response: a pilot study.
J Interv Card Electrophysiol. 2013 Apr;36(3):223-31. doi: 10.1007/s10840-012-9759-1. Epub 2012 Dec 21.
7
Clinical, laboratory, and pacing predictors of CRT response.临床、实验室和起搏预测 CRT 反应。
J Cardiovasc Transl Res. 2012 Apr;5(2):196-212. doi: 10.1007/s12265-012-9352-0. Epub 2012 Feb 24.
8
How to improve outcomes with cardiac resynchronisation therapy: importance of lead positioning.如何改善心脏再同步治疗的效果:导引线定位的重要性。
Heart Fail Rev. 2012 Nov;17(6):781-9. doi: 10.1007/s10741-011-9287-6.
9
Atrioventricular and interventricular delay optimization in cardiac resynchronization therapy: physiological principles and overview of available methods.房室和室间隔延迟优化在心脏再同步治疗中的应用:生理原理和现有方法概述。
Heart Fail Rev. 2011 May;16(3):263-76. doi: 10.1007/s10741-010-9215-1.
10
Maximum derivative of left ventricular pressure predicts cardiac mortality after cardiac resynchronization therapy.左心室压力最大导数可预测心脏再同步化治疗后的心脏死亡率。
Clin Cardiol. 2010 Dec;33(12):E18-23. doi: 10.1002/clc.20683. Epub 2010 Dec 8.